← Back to Search

Team Clinic Care for Type 1 Diabetes

N/A
Waitlist Available
Led By Jennifer K Raymond, MD, MCR
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of type 1 diabetes > 6 month duration
Be younger than 18 years old
Must not have
Significant comorbid medical conditions that would make the patient non-eligible for group participation (e.g. cystic fibrosis, uncontrolled thyroid disease)
Severe psychological diagnoses in parent or child that would make group participation difficult
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline (0), 3 months, 6 months, 9 months, 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is to study if the team clinic care model is more effective than standard care for patients with T1D.

Who is the study for?
This trial is for English-speaking middle and high school students with Type 1 Diabetes, who have been diagnosed for over 6 months. They shouldn't be in other group interventions or have serious medical conditions like cystic fibrosis, uncontrolled thyroid disease, or severe behavioral/psychological issues that could affect group participation.
What is being tested?
The study tests a new 'Team Clinic' care approach against standard care for managing Type 1 Diabetes. It involves virtual appointments and possibly in-person visits with a multidisciplinary team. Participants are randomly placed into one of four groups to compare the effects of these different approaches over 15 months.
What are the potential side effects?
Since this trial focuses on diabetes management through virtual care rather than medication, traditional side effects aren't expected. However, participants may experience varying levels of satisfaction or effectiveness with the virtual healthcare model.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 1 diabetes for over 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have major health issues like cystic fibrosis or uncontrolled thyroid disease.
Select...
Either my child or I have a severe mental health condition that makes group activities challenging.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline (0), 3 months, 6 months, 9 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline (0), 3 months, 6 months, 9 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hemoglobin A1C Progression
Hemoglobin A1C at Baseline
Number of Standard Care cohort participants completing appointments
+8 more
Secondary study objectives
Clinical Efficiency
Cost to Instituition
Cost to Institution
+19 more
Other study objectives
ADA and CCS standards
Clinical Variables
Diabetes Family Responsbility Questionnaire - Parent
+16 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Team Clinic: Virtual Team Clinic GroupExperimental Treatment1 Intervention
Participants will be invited to participate in online/virtual thematic group sessions led by Team Clinic group facilitators (e.g., RD, SW, RN) aimed at improving glycemic control and treatment adherence, increasing social supports and diabetes care satisfaction, and aid in the transition from caregiver led treatment to self care. o Patients and Family members attend their own online sessions: Energy Training, Proficiency Training, Resilience Training, Balance Training, Miscellaneous sessions - scheduled as needed
Group II: Team Clinic Care: No VTC GroupsExperimental Treatment1 Intervention
Participants attend quarterly visits (1 visit every 3months). Appointments scheduled for Telehealth (TH) (1 in-person visits) as decided by provider/patient and yearly team visit as needed • Providers will utilize a patient centered care approach to conducting appointments
Group III: Standard Care: Virtual Team ClinicExperimental Treatment1 Intervention
Appointments will continue as usually with provider (quarterly visits; 1 visit every 3 months), but will be referred for necessary care per usual methods (e.g., diabetes education or supportive services). o Patients and Family members attend their own online sessions: Energy Training, Proficiency Training, Resilience Training, Balance Training, Miscellaneous sessions - scheduled as needed
Group IV: Standard Care: No VTC GroupsExperimental Treatment1 Intervention
Appointments will continue as usually with provider (quarterly visits; 1 visit every 3 months), but will be referred for necessary care per usual methods (e.g., diabetes education or supportive services).

Find a Location

Who is running the clinical trial?

Children's Hospital Los AngelesLead Sponsor
249 Previous Clinical Trials
5,074,595 Total Patients Enrolled
University of Southern CaliforniaOTHER
946 Previous Clinical Trials
1,604,744 Total Patients Enrolled
Cedars-Sinai Medical CenterOTHER
512 Previous Clinical Trials
163,285 Total Patients Enrolled
Jennifer K Raymond, MD, MCRPrincipal InvestigatorChildren's Hospital Los Angeles
1 Previous Clinical Trials
82 Total Patients Enrolled

Media Library

Standard Care Clinical Trial Eligibility Overview. Trial Name: NCT04190368 — N/A
Type 1 Diabetes Research Study Groups: Team Clinic: Virtual Team Clinic Group, Team Clinic Care: No VTC Groups, Standard Care: Virtual Team Clinic, Standard Care: No VTC Groups
Type 1 Diabetes Clinical Trial 2023: Standard Care Highlights & Side Effects. Trial Name: NCT04190368 — N/A
Standard Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04190368 — N/A
~19 spots leftby Dec 2025